Search for a trial

A PHASE 1 STUDY OF CC-486 AS A SINGLE AGENT AND IN COMBINATION WITH CARBOPLATIN OR ABI-007 IN SUBJECTS WITH RELAPSED OR REFRACTORY SOLID TUMORS

Primary objective:the primary objective of the study is to evaluate the safety and to define the maximal tolerated dose or the maximal administered dose of CC-486 as a single agent, in combination with CBDCA or ABI-007 in subjects with relapsed or…